WELL Health's Canada-Only Strategy Gains Momentum With Buys -- Market Talk

Dow Jones06-03

1244 ET - WELL Health Technologies is continuing its Canada-focused play, buying up more clinics as it sheds its U.S. operations. The company closed two sizeable clinic acquisitions--Ontario Imaging Diagnostics, a diagnostic imaging and procedure care provider, and a 65% controlling interest in Quebec-based UnionMD--and now expects to exceed its previous adjusted Ebitda guidance of C$175-C$185 million. TD Cowen analyst David Kwan says move reaffirms "a significant re-rating as it sells its U.S. businesses and redeploys the capital into the very attractive Canadian market." He adds that the increased outlook, which is 4% above consensus, should help assuage concerns about company margins and expect the year-to-date share price outperformance to continue. Shares are up 3.7% to C$4.76. (adriano.marchese@wsj.com)

 

(END) Dow Jones Newswires

June 02, 2026 12:45 ET (16:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment